Journal
/
Investigación sobre el cáncer
/
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
JoVE Revista
Investigación sobre el cáncer
This content is Free Access.
JoVE Revista Investigación sobre el cáncer
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

12,843 Views

•

06:44 min

•

September 08, 2017

DOI:

10.3791/56327-v

DOI:
10.3791/56327-v

•

06:44 min
September 08, 2017

•

20 Views
, , , , ,
1Department of Pathology, Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai

Summary

Automatically generated

Resistance to cancer therapies contributes to disease progression and death. Determining the mechanistic underpinnings of resistance is crucial for improving therapeutic response. This manuscript details the protocol to generate taxane-resistant cell models of prostate cancer (PC) to help dissecting the pathways involved in progression to Docetaxel resistance in PC patients.

Explore More Videos

Docetaxel-resistant Prostate Cancer Cell ModelsCancer Cell ResistanceAnti-mitotic Therapy ResistanceDrug Response ModelsCell Line DevelopmentDU145 Cells22Rv1 CellsDose EscalationCell CultureTrypsinizationCell PassagingPooled Resistant Cells

Read Article

Cite this Article

Mohr, L., Carceles-Cordon, M., Woo, J., Cordon-Cardo, C., Domingo-Domenech, J., Rodriguez-Bravo, V. Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel. J. Vis. Exp. (127), e56327, doi:10.3791/56327 (2017).

Download .ris file

Copy

Share Video

.

Copy